Glycopyrrolate Injection
Product Images NDC 0143-9584

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0143-9584). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glycopyrrolate Injection Novaplus 1)

Chemical structure of glycopyrrolate, showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

Vial (Glycopyrrolate Injection Novaplus 2)

Label for Glycopyrrolate Injection USP, 0.2 mg/mL, in a 1 mL single dose vial. The label indicates the product contains benzyl alcohol and is for intramuscular (IM) or intravenous (IV) use. It is a prescription drug distributed by Hikma Pharmaceuticals USA Inc. under the Novaplus brand.*

FDA Label Image

Shelfpack (Glycopyrrolate Injection Novaplus 3)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL, in a package containing 25 single-dose vials of 1 mL each. The label indicates the product is for intramuscular or intravenous use and contains benzyl alcohol as a preservative. It specifies it is not for use in newborns and is distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Vial (Glycopyrrolate Injection Novaplus 4)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL strength in a 2 mL single dose vial. The label states the total dose as 0.4 mg per 2 mL. It indicates the presence of benzyl alcohol and specifies use by intramuscular (IM) or intravenous (IV) routes. The label also shows the NDC 0143-9586-01, distributor as Hikma Pharmaceuticals USA Inc., and includes the Novaplus logo along with a barcode. Lot and expiration date fields are blank.*

FDA Label Image

Shelfpack (Glycopyrrolate Injection Novaplus 5)

Label for Glycopyrrolate Injection, USP 0.4 mg per 2 mL (0.2 mg/mL) by Hikma Pharmaceuticals USA Inc. The label indicates the product consists of 25 single-dose vials, each containing 2 mL. It is for intramuscular or intravenous use and contains benzyl alcohol as a preservative. Warning states it is not for use in newborns.*

FDA Label Image

Vial (Glycopyrrolate Injection Novaplus 6)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL (1 mg per 5 mL) in a 5 mL multiple dose vial. The label indicates use for intramuscular or intravenous injection, warning it is not for use in newborns. It contains benzyl alcohol and includes storage instructions, manufacturer Hikma Pharmaceuticals USA Inc., and the Novaplus logo. Lot and expiration details are present but not filled in.*

FDA Label Image

Shelfpack (Glycopyrrolate Injection Novaplus 7)

Label for Glycopyrrolate Injection, USP 1 mg per 5 mL (0.2 mg/mL) multiple dose vials, containing 25 vials of 5 mL each. The label indicates it is for intramuscular (IM) or intravenous (IV) use, contains benzyl alcohol, and includes a warning stating it is not for use in newborns. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Vial (Glycopyrrolate Injection Novaplus 8)

Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg per 20 mL) multiple dose vial label. The vial contains 20 mL of injection intended for intramuscular or intravenous use. The label states it is not for use in newborns and contains benzyl alcohol as a preservative. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Shelfpack (Glycopyrrolate Injection Novaplus 9)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL strength. The product comes in 10 multiple dose vials of 20 mL each. It is intended for intramuscular (IM) or intravenous (IV) use and contains benzyl alcohol as a preservative. The label highlights storage instructions and a warning that it is not for use in newborns. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Layout 1 (Glycopyrrolate Injection Novaplus 10)

A small white label containing a QR code on the left and black printed text on the right. The text includes GTIN, serial number (SN), expiration date (EXP), and lot number (LOT) information for Glycopyrrolate injection. No additional product details or branding are visible on this label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.